Alternative promoters control UGT2B17-dependent androgen catabolism in prostate cancer and its influence on progression.

Abstract

BACKGROUND:

Perturbation of the major UGT2B17-dependent androgen catabolism pathway has the potential to affect prostate cancer (PCa) progression. The objective was to evaluate UGT2B17 protein expression in primary tumours in relation to hormone levels, disease characteristics and cancer evolution.

METHODS:

We conducted an analysis of a high-density prostate tumour tissue microarray consisting of 239 localised PCa cases treated by radical prostatectomy (RP). Cox proportional hazard ratio analysis was used to evaluate biochemical recurrence (BCR), and a linear regression model evaluated variations in circulating hormone levels measured by mass spectrometry. The transcriptome of UGT2B17 in PCa was established by using RNA-sequencing data.

RESULTS:

UGT2B17 expression in primary tumours was associated with node-positive disease at RP and linked to circulating levels of 3α-diol-17 glucuronide, a major circulating DHT metabolite produced by the UGT2B17 pathway. UGT2B17 was an independent prognostic factor linked to BCR after RP, and its overexpression was associated with development of metastasis. Finally, we demonstrated that distinctive alternative promoters dictate UGT2B17-dependent androgen catabolism in localised and metastatic PCa.

CONCLUSIONS:

The androgen-inactivating gene UGT2B17 is controlled by overlooked regulatory regions in PCa. UGT2B17 expression in primary tumours influences the steroidome, and is associated with relevant clinical outcomes, such as BCR and metastasis.

• Authors: Eric Lévesque, Adrien Labriet, Hélène Hovington, Éric P Allain, Luciana Melo-Garcia, Michèle Rouleau, Hervé Brisson, Véronique Turcotte, Patrick Caron, Lyne Villeneuve, Mickaël Leclercq, Arnaud Droit, Etienne Audet-Walsh, David Simonyan, Yves Fradet, Louis Lacombe, Chantal Guillemette
• Journal: British journal of cancer (Br J Cancer) Vol. 122 Issue 7 Pg. 1068-1076 (03 2020) ISSN: 1532-1827 [Electronic] England
• PMID: 32047296 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Androgens
• Minor Histocompatibility Antigens
• Glucuronosyltransferase
• UGT2B17 protein, human

Topics

• Adult
• Aged
• Androgens (metabolism)
• Disease Progression
• Glucuronosyltransferase (metabolism)
• Humans
• Male
• Middle Aged
• Minor Histocompatibility Antigens (metabolism)
• Prostatic Neoplasms (genetics, pathology)